doi: 10.1016/j.vaccine.2009.05.040.
Epub 2009 May 31.
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders
Affiliations
- PMID: 19490962
- DOI: 10.1016/j.vaccine.2009.05.040
Item in Clipboard
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders
Vaccine.
.
Abstract
Burkholderia pseudomallei and Burkholderia mallei are gram-negative bacilli that are the causative agents of melioidosis and glanders, respectively. Both humans and animals are susceptible to both diseases. There is currently no vaccine available for the prevention of disease. We report the protective efficacy of heat-inactivated Burkholderia thailandensis, B. mallei or B. pseudomallei cells as vaccines against murine melioidosis and glanders. Immunisation with heat-inactivated B. pseudomallei cells provided the highest levels of protection against either melioidosis or glanders. These studies indicate the longer term potential for heat-inactivated bacteria to be developed as vaccines against melioidosis and glanders.
Similar articles
-
Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.PLoS One. 2015 Jul 6;10(7):e0132032. doi: 10.1371/journal.pone.0132032. eCollection 2015. PLoS One. 2015. PMID: 26148026 Free PMC article.
-
Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?Vaccine. 2017 Oct 20;35(44):5981-5989. doi: 10.1016/j.vaccine.2017.03.022. Epub 2017 Mar 21. Vaccine. 2017. PMID: 28336210 Review.
-
Human single-chain Fv antibodies against Burkholderia mallei and Burkholderia pseudomallei.Exp Biol Med (Maywood). 2007 Apr;232(4):550-6. Exp Biol Med (Maywood). 2007. PMID: 17392491
-
Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.PLoS Negl Trop Dis. 2019 Jul 15;13(7):e0007578. doi: 10.1371/journal.pntd.0007578. eCollection 2019 Jul. PLoS Negl Trop Dis. 2019. PMID: 31306423 Free PMC article.
-
Development of Burkholderia mallei and pseudomallei vaccines.Front Cell Infect Microbiol. 2013 Mar 11;3:10. doi: 10.3389/fcimb.2013.00010. eCollection 2013. Front Cell Infect Microbiol. 2013. PMID: 23508691 Free PMC article. Review.
Cited by
-
Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice.Front Cell Infect Microbiol. 2012 Jun 15;2:85. doi: 10.3389/fcimb.2012.00085. eCollection 2012. Front Cell Infect Microbiol. 2012. PMID: 22919676 Free PMC article.
-
A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis.Clin Vaccine Immunol. 2014 May;21(5):747-54. doi: 10.1128/CVI.00119-14. Epub 2014 Mar 26. Clin Vaccine Immunol. 2014. PMID: 24671550 Free PMC article.
-
Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice.PLoS One. 2014 Dec 11;9(12):e115066. doi: 10.1371/journal.pone.0115066. eCollection 2014. PLoS One. 2014. PMID: 25503969 Free PMC article.
-
Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.Front Cell Infect Microbiol. 2012 Aug 15;2:108. doi: 10.3389/fcimb.2012.00108. eCollection 2012. Front Cell Infect Microbiol. 2012. PMID: 22912938 Free PMC article.
-
Evaluation of surrogate animal models of melioidosis.Front Microbiol. 2010 Dec 29;1:141. doi: 10.3389/fmicb.2010.00141. eCollection 2010. Front Microbiol. 2010. PMID: 21772830 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
